From the Department of Anesthesiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Department of Anesthesia, Lucille Packard Children's Hospital, Stanford University School of Medicine, Stanford, California.
Anesth Analg. 2021 Sep 1;133(3):562-568. doi: 10.1213/ANE.0000000000005519.
Electronic cigarettes (e-cigarettes) or vaping use in adolescents has emerged as a public health crisis that impacts the perioperative care of this vulnerable population. E-cigarettes have become the most commonly used tobacco products among youth in the United States. Fruit and mint flavors and additives such as marijuana have enticed children and adolescents. E-cigarette, or vaping, product use-associated lung injury (EVALI) is a newly identified lung disease linked to vaping. Clinical presentation of EVALI can be varied, but most commonly includes the respiratory system, gastrointestinal (GI) tract, and constitutional symptoms. Clinical management of EVALI has consisted of vaping cessation and supportive therapy, including supplemental oxygen, noninvasive ventilation, mechanical ventilation, glucocorticoids, and empiric antibiotics, until infectious causes are eliminated, and in the most severe cases, extracorporeal membrane oxygenation (ECMO). Currently, although there is an insufficient evidence to determine the safety and the efficacy of e-cigarettes for perioperative smoking cessation, EVALI clearly places these patients at an increased risk of perioperative morbidity. Given the relatively recent introduction of e-cigarettes, the long-term impact on adolescent health is unknown. As a result, the paucity of postoperative outcomes in this potentially vulnerable population does not support evidence-based recommendations for the management of these patients. Clinicians should identify "at-risk" individuals during preanesthetic evaluations and adjust the risk stratification accordingly. Our societies encourage continued education of the public and health care providers of the risks associated with vaping and nicotine use and encourage regular preoperative screening and postoperative outcome studies of patients with regard to smoking and vaping use.
电子烟(e-cigarettes)或蒸气使用在青少年中已经成为一个公共卫生危机,影响了这个脆弱人群的围手术期护理。电子烟已经成为美国青少年最常使用的烟草产品。水果和薄荷口味以及大麻等添加剂吸引了儿童和青少年。电子烟或蒸气产品相关肺损伤(EVALI)是一种新发现的与蒸气使用有关的肺病。EVALI 的临床表现多种多样,但最常见的是呼吸系统、胃肠道(GI)道和全身症状。EVALI 的临床治疗包括停止蒸气使用和支持性治疗,包括补充氧气、无创通气、机械通气、糖皮质激素和经验性抗生素,直到消除感染原因,并在最严重的情况下使用体外膜氧合(ECMO)。目前,尽管没有足够的证据来确定电子烟在围手术期戒烟方面的安全性和疗效,但 EVALI 显然使这些患者围手术期发病率增加。鉴于电子烟的引入相对较新,其对青少年健康的长期影响尚不清楚。因此,在这个潜在脆弱的人群中,术后结果的缺乏并不支持对这些患者进行基于证据的管理建议。临床医生应在术前评估中识别“高危”个体,并相应调整风险分层。我们的社会鼓励对公众和医疗保健提供者进行有关蒸气和尼古丁使用风险的持续教育,并鼓励对吸烟和蒸气使用患者进行常规术前筛查和术后结果研究。